Company Valuation: Amedisys

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Market Cap 1 5,384 9,624 5,278 2,714 3,102 2,974
Change - 78.76% -45.16% -48.57% 14.28% -4.14%
Enterprise Value (EV) 1 5,680 9,850 5,781 3,212 3,463 3,130
Change - 73.41% -41.31% -44.44% 7.82% -9.62%
P/E Ratio 43.5x 53.1x 25.5x 23x -317x 69.3x
PBR 8.41x 11.9x 5.65x 2.58x 2.91x 2.62x
PEG - 1.2x 1.7x -0.5x 3x -0x
Capitalization / Revenue 2.75x 4.65x 2.38x 1.22x 1.39x 1.27x
EV / Revenue 2.9x 4.75x 2.61x 1.44x 1.55x 1.33x
EV / EBITDA 28.8x 40.7x 20.5x 15.4x 16x 13.3x
EV / EBIT 31.7x 46.2x 23x 17.5x 17.9x 14.9x
EV / FCF 41.5x 25.7x 47.8x 26.3x 13.4x 11.3x
FCF Yield 2.41% 3.88% 2.09% 3.8% 7.47% 8.87%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 3.84 5.52 6.34 3.63 -0.3 1.31
Distribution rate - - - - - -
Net sales 1 1,956 2,072 2,214 2,223 2,236 2,348
EBITDA 1 197.4 241.8 282.5 208.7 216.9 235.6
EBIT 1 178.9 213 251.6 183.8 193.1 209.6
Net income 1 126.8 183.6 209.1 118.6 -9.747 43.23
Net Debt 1 295.8 225.2 502.9 497.4 360.8 156.1
Reference price 2 166.92 293.33 161.88 83.54 95.06 90.79
Nbr of stocks (in thousands) 32,255 32,811 32,602 32,492 32,633 32,754
Announcement Date 2/19/20 A 2/25/21 A 2/24/22 A 2/16/23 A 2/22/24 A 2/27/25 A
1USD in Million2USD
Estimates

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!